Curaleaf Holdings Inc CURA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Curaleaf Marks Seven Years and $600,000 Donated For Breast Cancer Action Month
-
Curaleaf to Report Third Quarter 2026 Financial and Operational Results
-
Aurora Cannabis Files Application with Alberta Securities Commission to Protect Company Shareholders Having Identified Several Deficiencies in Curaleaf's Hostile Bid Disclosure
-
Curaleaf Added to FTSE Canada All Cap Index
-
Curaleaf Relocates Hartford Dispensary to Meriden, Connecticut
-
Curaleaf Opens New Fishtown Dispensary, Expanding Access for Philadelphia Patients
-
Curaleaf Retail Presence Expands in Florida with Port Richey Dispensary Opening
-
Curaleaf Sends Letter to Aurora Shareholders
Trading Information
- Previous Close Price
- CA$14.62
- Day Range
- CA$14.00–14.85
- 52-Week Range
- CA$7.77–20.93
- Bid/Ask
- CA$14.37 / CA$14.37
- Shares Outstanding
- 264.81M
- Market Cap
- CA$3.88B
- Volume/Avg
- 199,275 / 299,739
Key Statistics
- Price/Earnings (Normalized)
- 158.83
- Price/Sales
- 2.20
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the US. The company has operations in 17 states. Its brands include Curaleaf, Select, and Grassroots. The company has made acquisitions that give it exposure to the growing European market, a unique feature among US multistate operators.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 5,519
- Website
- https://www.curaleaf.com
Valuation
|
Metric
|
CURA
|
|---|---|
Price/Earnings (Normalized) | 158.83 |
Price/Book Value | 3.15 |
Price/Sales | 2.20 |
Price/Cash Flow | 15.76 |
Price/Earnings
CURA
Financial Strength
|
Metric
|
CURA
|
|---|---|
Quick Ratio | 0.58 |
Current Ratio | 1.52 |
Interest Coverage | 0.06 |
Quick Ratio
CURA
Profitability
|
Metric
|
CURA
|
|---|---|
Return on Assets (Normalized) | 0.16% |
Return on Equity (Normalized) | 0.56% |
Return on Invested Capital (Normalized) | 5.29% |
Return on Assets
CURA
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|>$%H%zB | LOCK|Rv<@@ | $66B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|JMgK^lJ | LOCK|!Gz# | $46B | |||
| Haleon PLC ADR
HLN
| LOCK|#rDWY>Y | LOCK|yz | $38B | |||
| Zoetis Inc Class A
ZTS
| LOCK|Wc@!jd$ | LOCK|@jL | $29B | |||
| Viatris Inc
VTRS
| LOCK|RtC#NZw | LOCK|?qJ | $20B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|>Wp | LOCK|Ylt | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|Y%^##zg | LOCK|H& | $10B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|@%$Z!G> | LOCK|hY | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|SzMP!k | LOCK|hz>mD | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|M<HrR^h | LOCK|#s | $2B |
United States